ENHANCED PRODUCTION OF HUMAN MONOCLONAL-ANTIBODIES BY THE USE OF FRUCTOSE IN SERUM-FREE HYBRIDOMA CULTURE MEDIA

被引:16
|
作者
MOCHIZUKI, K
SATO, S
KATO, M
HASHIZUME, S
机构
[1] Morinaga Institute of Biological Science, Yokohama, 230, 2-1-1 Shimosueyoshi, Tsurumi-ku
关键词
ANTIBODY PRODUCTION; CULTURE MEDIUM; FRUCTOSE; GLUTAMINE; HUMAN MONOCLONAL ANTIBODY; LACTIC ACID;
D O I
10.1007/BF00749812
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
It was found that the production of human monoclonal antibodies (MoAbs) by human-human hybridomas can be significantly enhanced by replacing glucose with fructose in the dish culture medium. Optimization of initial concentrations of fructose and glutamine, another influencing factor for MoAb production, enabled an enhanced production of human MoAb 2.1 times higher than that obtained using the conventional culture media employing glucose. It was shown by kinetic analysis that enhanced MoAb production at the optimum fructose concentration can be attributed to the retention of high specific antibody production rates and diminished time lag during the course of culture. These dish culture results with fructose-containing medium were successfully applied to the continuous perfusion culture with a slight modification, where 2.9- and 1.9-fold enhancements in specific antibody production rate and MoAb concentration, respectively, were attained as compared with the conventional glucose-containing medium. An inverse relationship was observed between the secreted concentrations of lactic acid and MoAb when the hybridoma was cultured in the media containing varying concentrations of fructose, i.e., the lower the lactic acid concentration, the higher the MoAb production and vice versa, suggesting that fructose at appropriate concentrations in the medium can serve as an alternative sugar for the efficient production of human MoAbs, with reduced pH shifts, for the serum-free culture of human-human hybridomas.
引用
收藏
页码:161 / 173
页数:13
相关论文
共 50 条
  • [11] PRODUCTION OF MURINE MONOCLONAL-ANTIBODIES AGAINST HUMAN THYROGLOBULIN USING AN INVITRO IMMUNIZATION PROCEDURE IN SERUM-FREE MEDIUM
    OSSENDORP, FA
    DEBOER, M
    AL, BJM
    HILGERS, J
    BRUNING, PF
    TAGER, JM
    JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 91 (02) : 257 - 264
  • [12] ADAPTATION AND PRODUCTION OF MONOCLONAL-ANTIBODIES IN A LARGE-SCALE PERFUSION SYSTEM - ON LINE TRANSITION FROM SERUM-SUPPLEMENTED MEDIA TO SERUM-FREE MEDIA
    BROWN, BL
    HYBRIDOMA, 1986, 5 (01): : 59 - 59
  • [13] EFFECT OF INSULIN ON A SERUM-FREE HYBRIDOMA CULTURE
    ZHOU, WC
    HU, WS
    BIOTECHNOLOGY AND BIOENGINEERING, 1995, 47 (02) : 181 - 185
  • [14] STABILITY OF HYBRIDOMA CELL-POPULATIONS FOR THE PRODUCTION OF MONOCLONAL-ANTIBODIES - EFFECT OF SERUM
    OZTURK, SS
    CAMERON, MJ
    PALSSON, BO
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 198 : 169 - MBTD
  • [15] A METHOD FOR PRODUCTION OF HUMAN MONOCLONAL-ANTIBODIES TO HLA BY HUMAN-HUMAN HYBRIDOMA TECHNOLOGY
    HULETTE, C
    EFFROS, R
    WALFORD, R
    FEDERATION PROCEEDINGS, 1985, 44 (06) : 1881 - 1881
  • [16] PRODUCTION OF MONOCLONAL-ANTIBODIES IN CULTURE
    REUVENY, S
    VELEZ, D
    RISKE, F
    MACMILLAN, JD
    MILLER, L
    DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION, 1985, 60 : 185 - 197
  • [17] MONOCLONAL-ANTIBODIES, HYBRIDOMA TECHNOLOGY AND HETEROLOGOUS PRODUCTION SYSTEMS
    HIATT, AC
    CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (02) : 229 - 232
  • [18] A SERUM-FREE MEDIUM FOR HYBRIDOMA CELL-CULTURE
    CHEN, ZH
    KE, YZ
    CHEN, YL
    CYTOTECHNOLOGY, 1993, 11 (03) : 169 - 174
  • [19] INVITRO PRODUCTION OF MONOCLONAL-ANTIBODIES UNDER SERUM-FREE CONDITIONS USING A COMPACT AND INEXPENSIVE HOLLOW FIBER CELL-CULTURE UNIT
    KLERX, JPAM
    VERPLANKE, CJ
    BLONK, CG
    TWAALFHOVEN, LC
    JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 111 (02) : 179 - 188
  • [20] HYBRIDOMA MONOCLONAL-ANTIBODIES TO HUMAN-FETAL HEMOGLOBIN
    CUCINA, A
    REVOLTELLA, RP
    MANCINI, R
    DONOFRIO, G
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1984, 19 (04) : 307 - 313